Increased Risk of Acute Lymphoblastic Leukemia in Adult Patients with GSTM1 Null Genetic Polymorphism.
GSTM1
GSTT1
acute lymphoblastic leukemia
polymorphism
Journal
Pharmacogenomics and personalized medicine
ISSN: 1178-7066
Titre abrégé: Pharmgenomics Pers Med
Pays: New Zealand
ID NLM: 101514107
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
12
2021
accepted:
04
03
2022
entrez:
22
3
2022
pubmed:
23
3
2022
medline:
23
3
2022
Statut:
epublish
Résumé
Glutathione S-transferases (GSTT1 and GSTM1) detoxify various endogenous and exogenous compounds and provide cytoprotective role against reactive species. This study aimed to assess the frequency of This case-control study included 128 adult Sudanese, untreated newly diagnosed patients with ALL, aged 18 to 74 years and 128 age-gender matched healthy controls. Deletional polymorphisms of The genotypic frequency of Irrespective of age at diagnosis, gender, and phenotype of ALL, GSTM1 null polymorphism either alone or in combination with GSTT1 null polymorphism poses significantly increased risk of developing ALL in adults.
Identifiants
pubmed: 35313604
doi: 10.2147/PGPM.S356302
pii: 356302
pmc: PMC8934168
doi:
Types de publication
Journal Article
Langues
eng
Pagination
227-234Informations de copyright
© 2022 Abdalhabib et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Oncology. 2010;79(3-4):181-6
pubmed: 21358205
Arch Toxicol. 2016 May;90(5):1049-67
pubmed: 26993125
Front Oncol. 2021 Oct 14;11:714421
pubmed: 34722260
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):733-6
pubmed: 19256768
Blood. 2002 Jul 1;100(1):67-71
pubmed: 12070010
Leuk Res. 2006 Dec;30(12):1471-91
pubmed: 17023046
Asian Pac J Cancer Prev. 2013;14(4):2221-4
pubmed: 23725116
Blood. 1999 Mar 1;93(5):1496-501
pubmed: 10029576
Bosn J Basic Med Sci. 2019 Apr 15;19(4):350-354
pubmed: 30995900
Blood Cancer J. 2017 Jun 30;7(6):e577
pubmed: 28665419
Indian J Med Paediatr Oncol. 2011 Jan;32(1):25-9
pubmed: 21731212
Haematologica. 2007 Mar;92(3):308-14
pubmed: 17339179
Mayo Clin Proc. 2016 Nov;91(11):1645-1666
pubmed: 27814839
World J Clin Oncol. 2016 Oct 10;7(5):395-405
pubmed: 27777882
J Egypt Natl Canc Inst. 2006 Sep;18(3):264-73
pubmed: 17671537
Leukemia. 2002 Aug;16(8):1565-7
pubmed: 12145701
Hematology. 2015 Oct;20(9):511-6
pubmed: 25799091
Carcinogenesis. 2000 Jan;21(1):43-7
pubmed: 10607732
Pak J Med Sci. 2018 May-Jun;34(3):666-670
pubmed: 30034435
Asian Pac J Cancer Prev. 2020 Feb 01;21(2):499-503
pubmed: 32102530
Pharmgenomics Pers Med. 2021 Dec 22;14:1661-1667
pubmed: 34992428
Biochem Pharmacol. 2004 Sep 15;68(6):1101-11
pubmed: 15313406
Cell Chem Biol. 2016 May 19;23(5):567-578
pubmed: 27185638
Drug Metab Rev. 2011 May;43(2):266-80
pubmed: 21425939
Haematologica. 2000 Jun;85(6):573-9
pubmed: 10870112
Antioxidants (Basel). 2021 Apr 29;10(5):
pubmed: 33946704
Oncotarget. 2017 Jan 3;8(1):110-117
pubmed: 27058755
Asian Pac J Cancer Prev. 2014;15(5):2075-81
pubmed: 24716937
Am J Hematol. 2005 Jul;79(3):202-5
pubmed: 15981231
Eur J Cancer Prev. 2008 Jun;17(3):251-8
pubmed: 18414197
Eur J Cancer. 2005 May;41(7):980-9
pubmed: 15862746
Pediatr Blood Cancer. 2004 Oct;43(5):560-7
pubmed: 15382273
J Hum Genet. 2014 Sep;59(9):529-35
pubmed: 25102096